unknown
Stage
1
Investors
About
Ayala Pharmaceuticals develops and commercializes small molecule therapeutics targeting rare and aggressive cancers characterized by aberrant activation of the Notch pathway.
Explore Ayala Pharmaceuticals Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.